Earmarked funding – call 2022.2

€8 million for BioTech-MedTech & Digital Health

Earmarked funding for innovations in BioTech, MedTech and Digital Technology.

Disruptive innovations happen when different technology domains join forces.

In 2022 MEDVIA supported by VLAIO provides €8 million earmarked non-dilutive funding for innovations in biotechnology, medical technology, and digital technology.

The projects – combining at least two of the above domains – should develop disruptive solutions for a clearly defined unmet need in healthcare or pool their research strengths to gain knowledge that will lead to such solutions. The results need to lead to a quantifiable increase in investment and employment in Flanders.

Call for projects 2022.2

How to apply?

Your project should connect with one of our four overarching themes: Value-based healthcare, personalised medicine, digital medicine, or disruptive health solutions.

Full detail of the criteria and deadlines can be found in the PDF document.

Please note that this call is now in the full proposal phase. 

Full proposal templates

The full proposal deadline is on the 1st of September 2022.

Grant options.

We opened four different VLAIO grant schemes:

  • Feasibility study
  • Research Innovation Grant
  • Development Innovation Grant
  • ICON

We help you succeed.

MEDVIA assists participants with the preparation of their proposal. Of course, all participants bear full and final responsibility for writing and preparing a proposal that meets the criteria set by VLAIO for the respective grant schemes.

Interested in our future calls?